{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:53:02Z","timestamp":1787961182732,"version":"build-2784847793"},"reference-count":41,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IPRP"],"DOI":"10.2147\/iprp.s346395","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T15:10:10Z","timestamp":1641395410000},"page":"1-8","source":"Crossref","is-referenced-by-count":7,"title":["Prescribing Pattern of Dermatological Compounding in Ethiopia: The Case of ALERT Hospital"],"prefix":"10.2147","volume":"Volume 11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3539-536X","authenticated-orcid":true,"given":"Muluken Nigatu","family":"Selam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-0280","authenticated-orcid":true,"given":"Andualem","family":"Ababu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regasa","family":"Bayisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Abdella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edessa","family":"Diriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-0322","authenticated-orcid":true,"given":"Minychel","family":"Wale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-7054","authenticated-orcid":true,"given":"Tadesse","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfa","family":"Marew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-7828","authenticated-orcid":true,"given":"Assefa Mulu","family":"Baye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"Hay","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref2","first-page":"31","volume":"9","author":"Tegegne","year":"2018","journal-title":"J Basic Clin Pharma"},{"key":"ref3","unstructured":"Ethiopia Public Health Training Initiative (EPHTI). Module: common skin diseases; 2005. Available from: https:\/\/www.cartercenter.org\/resources\/pdfs\/health\/ephti\/library\/modules\/Degree\/CommonSkinDiseasesDegree.pdf. Accessed August 28, 2021."},{"key":"ref4","first-page":"304","volume":"2","author":"Joel","year":"2013","journal-title":"Sch Acad J Pharm"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.18231\/2394-2797.2018.0027","volume":"5","author":"Mohiuddin","year":"2018","journal-title":"Int J Pharm Chem Anal"},{"key":"ref6","unstructured":"Baum MZ. Pharmaceutical compounding: an essential piece of the health care reform puzzle; 2016. Available from: www.imprimisrx.com\/assets\/Imprimis-Drug-Pricing-Monograph.pdf. Accessed September 08, 2021."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2147\/RMHP.S300906","volume":"14","author":"Selam","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5539\/gjhs.v10n12p104","volume":"10","author":"Hapsari","year":"2018","journal-title":"Glob J Health Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0733-8635(05)70014-0","volume":"16","author":"Ling","year":"1998","journal-title":"Dermatol Clin"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/jphs.12297","volume":"10","author":"Yusuff","year":"2019","journal-title":"Pharm Health Serv Res"},{"key":"ref11","first-page":"231","volume":"7","author":"Krochmal","year":"1992","journal-title":"Adv Dermatol"},{"key":"ref12","unstructured":"USP. (795) pharmaceutical compounding - non sterile preparations; 2019. Available from: https:\/\/www.uspnf.com\/sites\/default\/files\/usp_pdf\/EN\/USPNF\/revisions\/gc795.pdf. Accessed August 28, 2021."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/j.2055-2335.2013.tb00209.x","volume":"43","author":"Lau","year":"2013","journal-title":"J Pharm Pract Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.22159\/ijpps.2017v9i2.15681","volume":"9","author":"Kristina","year":"2017","journal-title":"Int J Pharm Pharma Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1023\/B:PHAR.0000006521.41736.db","volume":"25","author":"Buurma","year":"2003","journal-title":"Pharm World Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/jppr2002324310","volume":"32","author":"Pappas","year":"2002","journal-title":"J Pharm Pract Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.2042-7174.1996.tb00852.x","volume":"4","author":"Lindblad","year":"1996","journal-title":"Int J Pharm Pract"},{"key":"ref18","first-page":"461","volume":"20","author":"Karara","year":"2016","journal-title":"Int J Pharm Compd"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/j.2055-2335.2007.tb00761.x","volume":"37","author":"Giam","year":"2007","journal-title":"J Pharm Pract Res"},{"key":"ref20","unstructured":"Ministry of Health. Ethiopian hospital services transformation guidelines; 2017. Available from: http:\/\/repository.iifphc.org\u203abitstream\u203ahandle. Accessed September 10, 2021."},{"key":"ref21","unstructured":"Ministry of Health \u2013 Ethiopia. Health sector transformation plan II 2020\/21\u20132024\/25. 2021. Available from: https:\/\/e-library.moh.gov.et\/library\/index.php\/knowledge-product\/health-sector-transformation-plan-ii-hstp-ii-2020-21-2024-25\/. Accessed September 10, 2021."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1651-2227.2003.tb00583.x","volume":"92","author":"Brion","year":"2003","journal-title":"Acta Paediatr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2431-13-81","volume":"13","author":"Richey","year":"2013","journal-title":"BMC Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1211\/ijpp.15.2.0008","volume":"15","author":"Kairuz","year":"2007","journal-title":"Int J Pharm Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref26","first-page":"293","volume":"63","author":"Schnopp","year":"2011","journal-title":"Minerva Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.sapharm.2012.08.067","volume":"8","author":"Wiedyaningsih","year":"2012","journal-title":"Res Social Adm Pharm"},{"key":"ref28","first-page":"2","volume":"32","author":"Seid","year":"2016","journal-title":"Ethiop Pharm J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.5897\/AJPP2015.4282","volume":"9","author":"Masupye","year":"2015","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1610-0387.2011.07764.x","volume":"10","author":"Korting","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/j354v16n04_08","volume":"16","author":"Winckler","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e7432","DOI":"10.1136\/bmj.e7432","volume":"345","author":"Shaughnessy","year":"2012","journal-title":"Br Med J"},{"key":"ref33","first-page":"s17","volume":"17","author":"Quertermous","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"ref34","unstructured":"Ethiopian Food and Drug Authority (EFDA). The food and medicine administration proclamation (No.1112\/2019); 2019. Available from: http:\/\/www.fmhaca.gov.et\/wp-content\/uploads\/2020\/06\/Food-and-Medicine-Administration-Proclamation-1112.pdf. Accessed December 06, 2021."},{"key":"ref35","unstructured":"Ministry of health-Ethiopia. National guideline for compounding of dermatological preparations; 2020. Available from: https:\/\/www.moh.gov.et\/ejcc\/sites\/default\/files\/2020-07\/Final_FMOH%20-%20National%20Guideline%20for%20Compounding%20of%20Dermatological%20Preparations.pdf. Accessed December 07, 2021."},{"key":"ref36","unstructured":"Ethiopian Food and Drug Authority (EFDA). Cosmetic manufacturing directive; 2020. Available from: http:\/\/www.fmhaca.gov.et\/wp-content\/uploads\/2020\/06\/Cosmetic-manufacturer-Directive-2020.pdf. Accessed December 06, 2021."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-013-0005-9","volume":"13","author":"Gudeman","year":"2013","journal-title":"Drugs R D"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2146\/ajhp130112","volume":"70","author":"Myers","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"ref39","unstructured":"FDA. Evaluation of bulk drug substances nominated for use in compounding under section 503B of the federal food, drug, and cosmetic act. Guidance for industry; 2019. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/evaluation-bulk-drug-substances-nominated-use-compounding-under-section-503b-federal-food-drug-and. Accessed December 07, 2021."},{"key":"ref40","unstructured":"Drug Administration and Control Authority (DACA) of Ethiopia. Standards for the establishment and practice of pharmaceutical compounding laboratory; 2002. Available from: http:\/\/www.ethiopianreview.com\/pdf\/001\/Labcomp.pdf. Accessed December 07, 2021."},{"key":"ref41","unstructured":"Ethiopian Food and Drug Authority (EFDA). Guideline for registration of low-risk medicines; 2020. Available from: http:\/\/www.fmhaca.gov.et\/publication\/guideline-for-registration-of-low-risk-medicines-2\/. Accessed December 07, 2021."}],"container-title":["Integrated Pharmacy Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=77384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=77384","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T15:10:28Z","timestamp":1641395428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/prescribing-pattern-of-dermatological-compounding-in-ethiopia-the-case-peer-reviewed-fulltext-article-IPRP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"URL":"https:\/\/doi.org\/10.2147\/iprp.s346395","relation":{},"ISSN":["2230-5254"],"issn-type":[{"value":"2230-5254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}